Picture of Amicus Therapeutics logo

FOLD — Amicus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Amicus Therapeutics Q1 Revenue USD 110.4 Million Vs. IBES Estimate USD 111.2 Million

May 09 (Reuters) - Amicus Therapeutics Q1 EPS USD -0.16.
* Q1 adjusted operating expenses USD 85.6 million
* Q1 operating expenses USD 124.6 million
* Q1 net income USD -48.4 million

Recent news on Amicus Therapeutics

See all news